Assessing authorship, study purpose and journals when evaluating clinical studies Part of a comprehensive series showing how to evaluate a clinical study or research paper. This article focuses on why it is important to consider the authors’ background, aims and where the article was published.…
Next frontier: crystallising the future of medicines The UK is taking a lead in creating the regulatory framework needed to manufacture medicines in space, which is a move that could pave the way for improved treatments for cancer and rare diseases.…
Regulator encourages development of microbiome-based medicines The Medicines and Healthcare products Regulatory Agency’s position paper is aimed to provide clarity on microbiome medicinal products and how to bring them forward “with confidence”.…
Virtual reality holds the promise of filling medicines manufacturing workforce gaps Will virtual reality technology enable the UK to meet the demands of training in the pharmaceutical industry and medicines manufacturing.…
Branded medicines levy cut under statutory scheme The Department of Health and Social Care said that the new 16.5% levy, a fall from the previous year’s 24.3%, will take effect from 1 July 2026.…
Advanced therapy medicinal products: a tsunami in clinical medicine Advanced therapy medicinal products offer life-changing benefits for patients with little to no alternative treatments, but realising their full potential requires action across the entire healthcare system.…
Government medicines manufacturing training scheme used by more than 2,000 people so far The RESILIENCE programme has been developed to provide training for people in the medicines manufacturing sector.…
Health news round up: AMR, pain and genitourinary cancers A weekly summary of important developments in pharmacy and health news that you may have missed.…
Why the UK must put medicines at the forefront of a new EU relationship Why the UK’s priorities need to change in terms of medicines regulation, which will ultimately determine whether future patients will benefit from affordable medicines supply.…
Regulators set out support for in-orbit pharmaceutical manufacturing In a joint statement, UK regulators said that the production of materials and products in space have the potential to offer higher quality medicines compared with those made on Earth.…
